|
GABARAPL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.50490000000647E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.73940000000639E-05 |
| Normal-vs-Stage2 |
7.902100E-02 |
| Normal-vs-Stage3 |
1.60780000002525E-06 |
| Normal-vs-Stage4 |
2.769700E-04 |
| Stage1-vs-Stage2 |
3.344800E-01 |
| Stage1-vs-Stage3 |
9.995700E-02 |
| Stage1-vs-Stage4 |
1.927350E-01 |
| Stage2-vs-Stage3 |
5.069900E-02 |
| Stage2-vs-Stage4 |
9.332400E-02 |
| Stage3-vs-Stage4 |
9.486600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.45310000044097E-07 |
| Normal-vs-AfricanAmerican |
4.432600E-01 |
| Normal-vs-Asian |
6.679400E-03 |
| Caucasian-vs-AfricanAmerican |
9.188300E-02 |
| Caucasian-vs-Asian |
3.427200E-01 |
| AfricanAmerican-vs-Asian |
4.442800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.2591000004013E-07 |
| Normal-vs-Female |
9.84240000000414E-05 |
| Male-vs-Female |
3.408400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.199950E-04 |
| Normal-vs-Age(41-60Yrs) |
4.628900E-04 |
| Normal-vs-Age(61-80Yrs) |
5.89369999999256E-05 |
| Normal-vs-Age(81-100Yrs) |
1.048080E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.200200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.243600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.590800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.204600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.628000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.969800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.684800E-01 |
| Classical-VS-Follicular |
2.424200E-01 |
| Classical-VS-Other |
6.335600E-01 |
| Classical-VS-Normal |
2.19549999999069E-05 |
| Tall-VS-Follicular |
9.552300E-02 |
| Tall-VS-Other |
9.843800E-01 |
| Tall-VS-Normal |
1.755830E-04 |
| Follicular-VS-Other |
4.620800E-01 |
| Follicular-VS-Normal |
3.653700E-02 |
| Other-VS-Normal |
1.718440E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.967790E-04 |
| Normal-vs-N1 |
4.34309999997051E-06 |
| N0-vs-N1 |
2.042300E-02 |
|
|
